Elisaf M - Search Results

1

Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity.

Tambaki AP, Rizos E, Tsimihodimos V, Tselepis AD, Elisaf M. Tambaki AP, et al. Among authors: elisaf m. J Cardiovasc Pharmacol Ther. 2004 Jun;9(2):91-5. doi: 10.1177/107424840400900204. J Cardiovasc Pharmacol Ther. 2004. PMID: 15309245

2

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Goudevenos JA, Chapman MJ, Elisaf M, Tselepis AD. Tsimihodimos V, et al. Among authors: elisaf m. Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):306-11. doi: 10.1161/hq0202.102918. Arterioscler Thromb Vasc Biol. 2002. PMID: 11834533 Clinical Trial.

3

Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.

Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Miltiadous G, Goudevenos JA, Cariolou MA, Chapman MJ, Tselepis AD, Elisaf M. Tsimihodimos V, et al. Among authors: elisaf m. J Lipid Res. 2002 Feb;43(2):256-63. J Lipid Res. 2002. PMID: 11861667 Free article.

4

Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?

Liberopoulos E, Karabina SA, Tselepis A, Bairaktari E, Nicolaides C, Pavlidis N, Elisaf M. Liberopoulos E, et al. Among authors: elisaf m. Oncology. 2002;62(2):115-20. doi: 10.1159/000048256. Oncology. 2002. PMID: 11914596

5

The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamide.

Achimastos A, Liberopoulos E, Nikas S, Bairaktari E, Miltiadous G, Tsimihodimos V, Elisaf M. Achimastos A, et al. Among authors: elisaf m. Curr Med Res Opin. 2002;18(2):59-63. doi: 10.1185/030079902125000273. Curr Med Res Opin. 2002. PMID: 12017210

6

Multiple metabolic abnormalities in a patient with the syndrome of inappropriate antidiuresis.

Rizos E, Liamis G, Elisaf M. Rizos E, et al. Among authors: elisaf m. Nephron. 2002 Jun;91(2):339-40. doi: 10.1159/000058416. Nephron. 2002. PMID: 12053077

7

Effects of fibrates on serum metabolic parameters.

Elisaf M. Elisaf M. Curr Med Res Opin. 2002;18(5):269-76. doi: 10.1185/030079902125000516. Curr Med Res Opin. 2002. PMID: 12240789 Review.

8

Acquired icthyosis: a paraneoplastic skin manifestation of Hodgkin's disease.

Rizos E, Milionis HJ, Pavlidis N, Elisaf MS. Rizos E, et al. Lancet Oncol. 2002 Dec;3(12):727. doi: 10.1016/s1470-2045(02)00928-2. Lancet Oncol. 2002. PMID: 12473513 No abstract available.

9

Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes.

Rizos E, Bairaktari E, Ganotakis E, Tsimihodimos V, Mikhailidis DP, Elisaf M. Rizos E, et al. Among authors: elisaf m. J Cardiovasc Pharmacol Ther. 2002 Oct;7(4):219-26. doi: 10.1177/107424840200700404. J Cardiovasc Pharmacol Ther. 2002. PMID: 12490967 Clinical Trial.

10

Acid-base and electrolyte disturbances in patients with hypercalcemia.

Milionis HJ, Rizos E, Liamis G, Nikas S, Siamopoulos KC, Elisaf MS. Milionis HJ, et al. South Med J. 2002 Nov;95(11):1280-7. South Med J. 2002. PMID: 12539994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

812 results

Search Page

Filters